HOOKIPA Pharma Inc.
SIDDHI Patel has a diverse background in clinical operations, starting as a Clinical Research Volunteer at Robert Wood Johnson University Hospital. With a Master of Science in Clinical Trial Science from Rutgers University, SIDDHI has worked in various roles such as Operations Manager at AD and Senior CTA at ICON plc. Currently serving as a Senior Specialist in Clinical Operations at HOOKIPA Pharma Inc., SIDDHI's experience includes conducting research on molecular characterization of rice genotypes during a project at Anand Agricultural University. Additional education includes a Pharmaceutical Management certificate from Cornell University and a Master of Science in Biotechnology from Ramnarain Ruia College.
HOOKIPA Pharma Inc.
At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead. As a company, we fight for innovation; we challenge ourselves to act authentically and transparently; we thrive on our differences; and we go for it, never giving up in our efforts to eliminate the suffering of people with cancer and infectious disease. To learn more please visit www.hookipapharma.com.